2008 Archive
2007 Archive
2006 Archive
2005 Archive
2004 Archive
2003 Archive
2002 Archive
2001 Archive
2000 Archive
1999 Archive
PROTEOME SCIENCES APPOINTS DR GÜNTER SCHMIDT AS NON-EXECUTIVE DIRECTOR 4th June 2001
PRELIMINARY STATEMENT FOR THE 12 MONTHS TO 31 DECEMBER 2000 HIGHLIGHTS 16th May 2001
PROTEOME SCIENCES APPOINTS DR ANTHONY WALKER AS NON-EXECUTIVE DIRECTOR 14th May 2001
PROTEOME SCIENCES AND MINDSET COMBINE EXPERTISE AND RECEIVE GRANT TO ESTABLISH PROTEIN MARKERS IN MAJOR ALZHEIMER'S DISEASE RESEARCH PROGRAMME 11th April 2001
PROTEOME SCIENCES ASSOCIATE, INTRONN, ANNOUNCES HPV AND CERVICAL CANCER R&D AGREEMENT WITH NATIONAL CANCER INSTITUTE USING INTRONN'S SMaRT™ TECHNOLOGY 3rd April 2001
PROTEOME SCIENCES ESTABLISHES A MAJOR HIGH SENSITIVITY PROTEOMICS REASEARCH FACILITY AT KING'S COLLEGE, LONDON AND ANNOUNCES COLLABORATION WITH THE INSTITUTE OF PSYCHIATRY (KCL) TO ADDRESS A RANGE OF NEURODEGENERATIVE DISEASES 26 March 2001
PROTEOME SCIENCES ANNOUNCES THAT ITS US SUBSIDIARY, INTRONN, HAS ACHIEVED A MAJOR MILESTONE IN GENE SPLICING USING ITS SMART™ PROPRIETARY TECHNOLOGY PLATFORM 9th January 2001
© Proteome Sciences 2007
From the Genome to the Proteome
Business Strategy
Facilities
Management
Intronn Inc
Veri-Q Inc
Neurological Diseases
Solid Organ Transplant Rejection
Diabetes & Obesity
Oncology
ProteoSHOP®
Licensing
Stroke
TSEs
Alzheimer’s
Scientific
Grants
Press Releases
Investor Relations
Share Price
Report & Accounts
Key Events
Scientific Posters & Abstracts
Corporate History
Job Opportunities